---
figid: PMC6600375__ijms-20-02767-g007
figlink: /pmc/articles/PMC6600375/figure/ijms-20-02767-f007/
number: F7
caption: Targeting the TGF-β signaling pathway in cancer. Various molecular mechanisms
  by which TGF-β signaling is targeted for therapeutic gain are depicted. TGF-β inhibitory
  targeting agents (), including TβRI kinase inhibitors, AON targeting ligand or receptor
  gene expression, and antibodies interfering with ligand-receptor interactions, have
  been developed to curtail excessive TGF-β pathway activation. Inhibitory signals
  are indicated with inhibitory red arrows; Stimulatory signals are indicated with
  green arrows.
pmcid: PMC6600375
papertitle: TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
reftext: Yang Hao, et al. Int J Mol Sci. 2019 Jun;20(11):2767.
pmc_ranked_result_index: '8075'
pathway_score: 0.9477791
filename: ijms-20-02767-g007.jpg
figtitle: Targeting the TGFB signaling pathway in cancer
year: '2019'
organisms:
- Homo sapiens
ndex: d5dde405-de9a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6600375__ijms-20-02767-g007.html
  '@type': Dataset
  description: Targeting the TGF-β signaling pathway in cancer. Various molecular
    mechanisms by which TGF-β signaling is targeted for therapeutic gain are depicted.
    TGF-β inhibitory targeting agents (), including TβRI kinase inhibitors, AON targeting
    ligand or receptor gene expression, and antibodies interfering with ligand-receptor
    interactions, have been developed to curtail excessive TGF-β pathway activation.
    Inhibitory signals are indicated with inhibitory red arrows; Stimulatory signals
    are indicated with green arrows.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMAD6
  - SMAD7
  - TGFBR1
  - SMAD5
  - SMAD3
  - SMAD9
  - TGFB2
  - TGFB1
  - TGFBR2
  - SMAD4
  - SMAD1
  - TGFB3
  - SMAD2
  - LY2157299
  - GW788388
  - Levonorgestrel
  - TAG
  - pomalidomide
  - temozolomide
  - carboplatin
  - gemcitabine
  - lomustine
  - paclitaxel
  - capecitabine
  - soRAFenib
  - RegoRAFenib
  - Enzalutamide
  - IMC
genes:
- word: SMAD/non-SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: SMAD/non-SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: TBRI
  symbol: TBR-i
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: SMAD/non-SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: SMAD/non-SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD/non-SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: '|TBRII'
  symbol: TBRII
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: TBRII)
  symbol: TBR-ii
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: SMAD/non-SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD/non-SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: SMAD/non-SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
chemicals:
- word: LY2157299
  source: MESH
  identifier: C557799
- word: GW788388
  source: MESH
  identifier: C509927
- word: Levonorgestrel
  source: MESH
  identifier: D016912
- word: TAG
  source: MESH
  identifier: C069631
- word: pomalidomide
  source: MESH
  identifier: C467566
- word: temozolomide
  source: MESH
  identifier: C047246
- word: carboplatin
  source: MESH
  identifier: D016190
- word: gemcitabine
  source: MESH
  identifier: C056507
- word: lomustine
  source: MESH
  identifier: D008130
- word: paclitaxel
  source: MESH
  identifier: D017239
- word: capecitabine
  source: MESH
  identifier: C110904
- word: soRAFenib
  source: MESH
  identifier: C090505
- word: RegoRAFenib
  source: ''
  identifier: ''
- word: Enzalutamide
  source: MESH
  identifier: C540278
- word: IMC
  source: MESH
  identifier: C020760
diseases: []
figid_alias: PMC6600375__F7
redirect_from: /figures/PMC6600375__F7
figtype: Figure
---
